429 related articles for article (PubMed ID: 25985292)
21. The A53E α-synuclein pathological mutation demonstrates reduced aggregation propensity in vitro and in cell culture.
Rutherford NJ; Giasson BI
Neurosci Lett; 2015 Jun; 597():43-8. PubMed ID: 25892596
[TBL] [Abstract][Full Text] [Related]
22. 4-Arylidene curcumin derivatives in vitro inhibit α-Synuclein aggregation and disaggregate the preformed fibril.
Liu W; Zhang W; Xing LZ; Zhao YD; Xu J; Li RJ; Zhang YX
Bioorg Med Chem; 2023 Dec; 96():117529. PubMed ID: 37976808
[TBL] [Abstract][Full Text] [Related]
23. Implementing Complementary Approaches to Shape the Mechanism of α-Synuclein Oligomerization as a Model of Amyloid Aggregation.
Giampà M; Amundarain MJ; Herrera MG; Tonali N; Dodero VI
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011320
[TBL] [Abstract][Full Text] [Related]
24. Copper Binding and Subsequent Aggregation of α-Synuclein Are Modulated by N-Terminal Acetylation and Ablated by the H50Q Missense Mutation.
Mason RJ; Paskins AR; Dalton CF; Smith DP
Biochemistry; 2016 Aug; 55(34):4737-41. PubMed ID: 27517125
[TBL] [Abstract][Full Text] [Related]
25. Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy.
Paleologou KE; Irvine GB; El-Agnaf OM
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1106-10. PubMed ID: 16246056
[TBL] [Abstract][Full Text] [Related]
26. A SUMO1-Derived Peptide Targeting SUMO-Interacting Motif Inhibits α-Synuclein Aggregation.
Liang Z; Chan HYE; Lee MM; Chan MK
Cell Chem Biol; 2021 Feb; 28(2):180-190.e6. PubMed ID: 33444530
[TBL] [Abstract][Full Text] [Related]
27. Curcumin modulates α-synuclein aggregation and toxicity.
Singh PK; Kotia V; Ghosh D; Mohite GM; Kumar A; Maji SK
ACS Chem Neurosci; 2013 Mar; 4(3):393-407. PubMed ID: 23509976
[TBL] [Abstract][Full Text] [Related]
28. Anle138b and related compounds are aggregation specific fluorescence markers and reveal high affinity binding to α-synuclein aggregates.
Deeg AA; Reiner AM; Schmidt F; Schueder F; Ryazanov S; Ruf VC; Giller K; Becker S; Leonov A; Griesinger C; Giese A; Zinth W
Biochim Biophys Acta; 2015 Sep; 1850(9):1884-90. PubMed ID: 26028294
[TBL] [Abstract][Full Text] [Related]
29. The emerging role of α-synuclein truncation in aggregation and disease.
Sorrentino ZA; Giasson BI
J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039
[TBL] [Abstract][Full Text] [Related]
30. Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity.
Villar-Piqué A; Lopes da Fonseca T; Sant'Anna R; Szegö ÉM; Fonseca-Ornelas L; Pinho R; Carija A; Gerhardt E; Masaracchia C; Abad Gonzalez E; Rossetti G; Carloni P; Fernández CO; Foguel D; Milosevic I; Zweckstetter M; Ventura S; Outeiro TF
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6506-E6515. PubMed ID: 27708160
[TBL] [Abstract][Full Text] [Related]
31. The Familial α-Synuclein A53E Mutation Enhances Cell Death in Response to Environmental Toxins Due to a Larger Population of Oligomers.
Mohite GM; Navalkar A; Kumar R; Mehra S; Das S; Gadhe LG; Ghosh D; Alias B; Chandrawanshi V; Ramakrishnan A; Mehra S; Maji SK
Biochemistry; 2018 Aug; 57(33):5014-5028. PubMed ID: 30025458
[TBL] [Abstract][Full Text] [Related]
32. Loss in Toxic Function of Aggregates of α -Synuclein Mutants by a β-Synuclein Derived Peptide.
Mohammadi S; Nikkhah M; Hosseinkhani S
Protein Pept Lett; 2017; 24(8):757-764. PubMed ID: 28820063
[TBL] [Abstract][Full Text] [Related]
33. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.
Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143
[TBL] [Abstract][Full Text] [Related]
34. Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements.
Ruf VC; Nübling GS; Willikens S; Shi S; Schmidt F; Levin J; Bötzel K; Kamp F; Giese A
ACS Chem Neurosci; 2019 Mar; 10(3):1649-1659. PubMed ID: 30605594
[TBL] [Abstract][Full Text] [Related]
35. Self-Assembled Cyclic d,l-α-Peptides as Generic Conformational Inhibitors of the α-Synuclein Aggregation and Toxicity: In Vitro and Mechanistic Studies.
Chemerovski-Glikman M; Rozentur-Shkop E; Richman M; Grupi A; Getler A; Cohen HY; Shaked H; Wallin C; Wärmländer SK; Haas E; Gräslund A; Chill JH; Rahimipour S
Chemistry; 2016 Sep; 22(40):14236-46. PubMed ID: 27539220
[TBL] [Abstract][Full Text] [Related]
36. E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation.
Íñigo-Marco I; Valencia M; Larrea L; Bugallo R; Martínez-Goikoetxea M; Zuriguel I; Arrasate M
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8274-E8283. PubMed ID: 28900007
[TBL] [Abstract][Full Text] [Related]
37. Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.
Takahashi R; Ono K; Takamura Y; Mizuguchi M; Ikeda T; Nishijo H; Yamada M
J Neurochem; 2015 Sep; 134(5):943-55. PubMed ID: 26016728
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Kinetics, Toxicity, Oligomer Formation, and Membrane Binding Capacity of α-Synuclein Familial Mutations at the A53 Site, Including the Newly Discovered A53V Mutation.
Mohite GM; Kumar R; Panigrahi R; Navalkar A; Singh N; Datta D; Mehra S; Ray S; Gadhe LG; Das S; Singh N; Chatterjee D; Kumar A; Maji SK
Biochemistry; 2018 Sep; 57(35):5183-5187. PubMed ID: 29771508
[TBL] [Abstract][Full Text] [Related]
39. Dimerization propensities of Synucleins are not predictive for Synuclein aggregation.
Eckermann K; Kügler S; Bähr M
Biochim Biophys Acta; 2015 Aug; 1852(8):1658-64. PubMed ID: 25960149
[TBL] [Abstract][Full Text] [Related]
40. Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity.
Sanjeev A; Mattaparthi VSK
J Biomol Struct Dyn; 2018 Jul; 36(9):2224-2236. PubMed ID: 28650719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
